Policy & Medicine August 16, 2024
In a recent episode of “Oncology Update,” Dr. John Marshall from Georgetown University provided a comprehensive review of the current landscape in oncology, highlighting industry shifts, strategic mergers, and the pivotal discussions set for this year’s ASCO meeting. This episode offers valuable insights for healthcare professionals navigating the evolving oncology environment.
Industry Dynamics: Layoffs, Dose Reductions, and Drug Withdrawals
The oncology sector is witnessing significant transformations with major pharmaceutical companies like Bayer, Biogen, and Novartis announcing layoffs as part of restructuring efforts to streamline operations. These changes underscore a broader trend towards leaner organizational structures amidst economic pressures. For more details, see the full report on Bayer’s restructuring on FiercePharma.
Additionally, there’s an emerging trend towards optimizing drug dosages to...
Today's Sponsors
Today's Sponsor